A dexamethasone, melphalan, actinomycin‐D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5829|16|1|E144-E151

ISSN： 1476-5810

Source： VETERINARY AND COMPARATIVE ONCOLOGY, Vol.16, Iss.1, 2018-03, pp. : E144-E151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral melphalan for the treatment of relapsed canine lymphoma

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E123-E129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 4, 2015-12 ,pp. : 398-408

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E30-E37

John Wiley & Sons Inc

Access to resources Recommend Favorite

LOPP chemotherapy as a first‐line treatment for dogs with T‐cell lymphoma

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : 108-113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 4, 2015-12 ,pp. : 363-372

John Wiley & Sons Inc

Access to resources Recommend Favorite